Stereotactic body radiotherapy compared with video‐assisted thoracic surgery after propensity‐score matching in elderly patients with pathologically‐proven early‐stage non‐small cell lung cancer

Stereotactic body radiotherapy compared with video‐assisted thoracic surgery after propensity‐score matching in elderly patients with pathologically‐proven early‐stage non‐small cell lung cancer

Abstract Objective Standard medical treatment for early non‐small cell lung cancer (NSCLC) is surgery; however, stereotactic body radiotherapy (SBRT) can be a viable substitute for elderly patients who can no longer tolerate or refuse surgery. The unsurpassed care for elderly patients with early NSC...

Full description

Bibliographic Details
Main Authors:	Xiao‐ye Liu, Miao‐Miao Gao, Ze‐yuan Cheng, Zheng‐Kun Cai, Lu Yu, Geng‐Min Niu, Jun‐Yi Li, Yu Bai, Shu‐Zhou Zhao, Yong‐Chun Song, Xiao‐Guang Wang, Yang Dong, Xu‐yao Yu, Zhen Tao, Zhi‐Yong Yuan
Format:	Article
Language:	English
Published:	Wiley 2022-12-01
Series:	Precision Radiation Oncology
Subjects:	early‐stage elderly non‐small cell lung cancer stereotactic body radiotherapy surgery
Online Access:	https://doi.org/10.1002/pro6.1175

Similar Items

Stereotactic Radiosurgery/Radiotherapy: A Historical Review
by: Mansoureh Nabavi, et al.
Published: (2014-04-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
by: Harish N. Vasudevan, et al.
Published: (2017-06-01)

Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases
by: Sofian Benkhaled, et al.
Published: (2024-03-01)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
by: Bin Qiu, et al.
Published: (2020-08-01)

Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01)

Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
by: Chi-Leung Chiang, et al.
Published: (2021-12-01)

Stereotactic ablative radiotherapy for primary renal cell carcinoma
by: Daniel X. Yang, et al.
Published: (2024-01-01)

Neoadjuvant Stereotactic Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis of the Literature and Ongoing Clinical Trials
by: Paolo Palmisciano, et al.
Published: (2022-09-01)

Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01)

Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
by: Laura Burgess, et al.
Published: (2020-10-01)

A framework for exactrac dynamic commissioning for stereotactic radiosurgery and stereotactic ablative radiotherapy
by: Ben Perrett, et al.
Published: (2022-01-01)

Stereotactic radiotherapy: An educational narrative review
by: Agha Muhammad Hammad Khan, et al.
Published: (2024-03-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Stereotactic Radiotherapy in Uveal Melanoma
by: Ela Delikgöz Soykut, et al.
Published: (2014-09-01)

Effect of stereotactic radiotherapy on immune microenvironment of lung cancer
by: Yao Xiao, et al.
Published: (2022-09-01)

Palliative Efficacy of High-Dose Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Painful Non-Spine Bone Metastases: A Propensity Score-Matched Analysis
by: Kei Ito, et al.
Published: (2022-08-01)

Stereotactic Radiotherapy for Oligometastasis
by: Sotaro Otake, et al.
Published: (2019-01-01)

A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy
by: Ran Zhang, et al.
Published: (2021-08-01)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
by: Barney Brandon M, et al.
Published: (2012-05-01)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2019-09-01)

Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer
by: Sweet Ping Ng, et al.
Published: (2018-03-01)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
by: Robert Olson, et al.
Published: (2018-10-01)

Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
by: Raphael Jumeau, et al.
Published: (2020-06-01)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2020-12-01)

Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors
by: Atalar Banu, et al.
Published: (2020-06-01)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
by: Yining Gong, et al.
Published: (2019-10-01)

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study
by: Yang-Xun Pan, et al.
Published: (2019-08-01)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
by: Xue-Yi Xie, et al.
Published: (2022-07-01)

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
by: Shih-Ming Hsu, et al.
Published: (2017-09-01)

Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases
by: Leonie Johannwerner, et al.
Published: (2023-04-01)

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer
by: Katrina Woodford, et al.
Published: (2017-10-01)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
by: Jiang Xue-song, et al.
Published: (2012-03-01)

Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison
by: Mami Ogita, et al.
Published: (2021-06-01)

A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non–Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis
by: Shi-Wang Wen, et al.
Published: (2019-01-01)

Effect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy
by: Osamu Tanaka, et al.
Published: (2022-07-01)

Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma
by: Rohit K. Raj, et al.
Published: (2023-12-01)

Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases
by: Gamze Ugurluer, et al.
Published: (2024-05-01)

Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma
by: Xiao-Yao Feng, et al.
Published: (2022-09-01)

Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
by: Bin Wang, et al.
Published: (2022-04-01)